Expression of natural killer cell activating receptors in patients with chronic lymphocytic leukaemia (Q82293019)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22044312%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Expression of natural killer cell activating receptors in patients with chronic lymphocytic leukaemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22044312%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22044312%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Benjamin Knoblauch

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22044312%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Carole Sanchez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22044312%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Delphine Mercier

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22044312%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Thérèse Le Treut

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22044312%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Gérard Sébahoun

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22044312%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

1 February 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22044312%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22044312%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

135

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22044312%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22044312%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

151-157

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22044312%20AND%20SRC:MED&resulttype=core&format=json

Impaired natural killer activity in patients with chronic lymphocytic leukemia is associated with a deficiency of azurophilic cytoplasmic granules in putative NK cells

15 January 2020

cites work

1 reference

12 December 2020

Restoration of impaired natural killer cell activity of B-chronic lymphocytic leukemia patients by recombinant interleukin-2

1 reference

12 December 2020

Clinical signification of natural killer activity in B-cell chronic lymphocytic leukemia

1 reference

12 December 2020

Natural history of chronic lymphocytic leukemia: on the progression and progression and prognosis of early clinical stages

1 reference

12 December 2020

Differences in blood T and NK cell populations between chronic lymphocytic leukemia of B cell type (B-CLL) and monoclonal B-lymphocytosis of undetermined significance (B-MLUS).

1 reference

12 December 2020

T-cell activation and subset patterns are altered in B-CLL and correlate with the stage of the disease

1 reference

12 December 2020

Immune function of patients receiving recombinant human interleukin-6 (IL-6) in a phase I clinical study: induction of C-reactive protein and IgE and inhibition of natural killer and lymphokine-activated killer cell activity

1 reference

12 December 2020

Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome

1 reference

12 December 2020

Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia

1 reference

12 December 2020

Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells

1 reference

12 December 2020

Down-regulation of HLA-A and HLA-Bw6, but not HLA-Bw4, allospecificities in leukemic cells: an escape mechanism from CTL and NK attack?

1 reference

12 December 2020

Interleukin-6 (IL-6) expression and natural killer (NK) cell dysfunction and anergy in heart failure

1 reference

12 December 2020

Deficiency of natural killer cell activity in patients with chronic lymphocytic leukemia

1 reference

12 December 2020

Transforming growth factor beta as endogenous growth inhibitor of chronic lymphocytic leukemia B cells

1 reference

12 December 2020

Interleukin-13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia B cells from in vitro apoptosis

1 reference

12 December 2020

Defective natural killer cell activity in B-cell chronic lymphocytic leukaemia is associated with impaired release of natural killer cytotoxic factor(s) but not of tumour necrosis factor-alpha

1 reference

12 December 2020

Autocrine transforming growth factor-beta from chronic lymphocytic leukemia-B cells interferes with proliferative T cell signals.

1 reference

12 December 2020

Deficient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction.

1 reference

12 December 2020

Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells

1 reference

12 December 2020

Post-consolidation immunotherapy with histamine dihydrochloride and interleukin-2 in AML.

1 reference

12 December 2020

Regulation of human NK-cell cytokine and chemokine production by target cell recognition.

1 reference

12 December 2020

Immunotherapy with histamine dihydrochloride for the prevention of relapse in acute myeloid leukemia

1 reference

12 December 2020

Treatment of younger patients with chronic lymphocytic leukemia.

1 reference

12 December 2020

Natural killer cells and malignant haemopathies: a model for the interaction of cancer with innate immunity

1 reference

12 December 2020

10.1111/J.1365-2567.2011.03521.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22044312%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference